Advertisement
Video ThumbnailVideo Thumbnail
Updated: May 14, 2021, 10:15 AM IST

DNA DGCI approves Covaxin clinical trials for 2-18 year olds

The Drugs Controller General of India (DCGI) on Thursday (May 13) approved Bharat Biotech's covariate trials on children aged 2 to 18 years. Bharat Biotech said its Phase II and Phase III trials would be conducted on "525 healthy volunteers".

Advertisement

The Drugs Controller General of India (DCGI) on Thursday (May 13) approved Bharat Biotech's covariate trials on children aged 2 to 18 years. Bharat Biotech said its Phase II and Phase III trials would be conducted on "525 healthy volunteers".

Advertisement
Advertisement
Advertisement